Patient Enrollment Marketing for Phase III Oncology Drug Study- US & Europe

February 9, 2018

 

Challenge

Create an effective strategy for sites in the US and Europe, considering high sensitivity with Oncology sites and patients to identify and recruit patients with very strict I/E criteria for existing chemotherapy patients having either solid tumor or hematologic malignancies.

Solution

Implemented our ThreeWire Chart Review™ and Enrollment Assistantservices at selected sites in Europe and the US, along with a study website and support materials for 45 countries.

Results

Reviewed a total of 3,871 charts, with 1,095 passing pre-screening. Contributed a total of 102 enrollments across 14 sites. The highest enrolling site was one which utilized our Enrollment Assistant service.

Previous Flipbook
Patient Enrollment Marketing for Phase II COPD Drug Study- US & Canada
Patient Enrollment Marketing for Phase II COPD Drug Study- US & Canada

Randomize 200 subjects in 45 days, including obtaining IRB approval, and launching the recruitment program ...

Next Flipbook
Patient Enrollment Marketing for Prostate Cancer Study
Patient Enrollment Marketing for Prostate Cancer Study

Challenge Launch a multiyear, direct-to-patient marketing campaign for a breakthrough technology that provi...